Cargando…

Estimation of historical control rate for a single arm de-escalation study – Application to the POSITIVE trial

BACKGROUND: Although randomized controlled clinical trials are optimal to evaluate the effect of an experimental therapy, single-arm trials are required whenever randomization is unethical or not feasible, such as de-escalation studies. We propose using prospectively identified historical controls t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Zhuoxin, Niman, Samuel M., Pagani, Olivia, Partridge, Ann H., Azim, Hatem A., Peccatori, Fedro A., Ruggeri, Monica, Di Leo, Angelo, Colleoni, Marco, Gelber, Richard D., Regan, Meredith M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7375555/ https://www.ncbi.nlm.nih.gov/pubmed/32535486 http://dx.doi.org/10.1016/j.breast.2020.05.012

Ejemplares similares

Locoregional treatment of breast cancer during pregnancy
por: Toesca, Antonio, et al.
Publicado: (2014)

Who are the women who enrolled in the POSITIVE trial: A global study to support young hormone receptor positive breast cancer survivors desiring pregnancy()
por: Partridge, Ann H., et al.
Publicado: (2021)

Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT
por: Pagani, Olivia, et al.
Publicado: (2020)

Chemotherapy and anti-HER2 therapy in metastatic breast cancer in pregnancy followed by surgical treatment
por: Berwart, Julia, et al.
Publicado: (2019)

Seeing beyond COVID-19: understanding the impact of the pandemic on oncology, and the importance of preparedness
por: Carrieri, Daniele, et al.
Publicado: (2020)

RANK-ligand (RANKL) expression in young breast cancer patients and during pregnancy
por: Azim, Hatem A, et al.
Publicado: (2015)

Breast cancer diagnosed during pregnancy is associated with enrichment of non-silent mutations, mismatch repair deficiency signature and mucin mutations
por: Nguyen, Bastien, et al.
Publicado: (2018)

COVID-19: a plea to protect the older population
por: Carrieri, Daniele, et al.
Publicado: (2020)

The Oncohumanities training programme: Fostering a deeper engagement and integration of oncology and humanities to tackle the pressing and complex challenges of cancer care
por: Carrieri, Daniele, et al.
Publicado: (2023)

Improved adjuvant endocrine therapy for premenopausal women with endocrine responsive disease
por: Goldhirsch, Aron, et al.
Publicado: (2015)

Psychological issues and construction of the mother-child relationship in women with cancer during pregnancy: a perspective on current and future directions
por: Ferrari, Federica, et al.
Publicado: (2018)

PERSEPHONE: are we ready to de-escalate adjuvant trastuzumab for HER2-positive breast cancer?
por: Pondé, Noam, et al.
Publicado: (2019)

Biology of breast cancer in young women
por: Azim, Hatem A, et al.
Publicado: (2014)

Guidelines for Cancer Treatment during Pregnancy: Ethics-Related Content Evolution and Implications for Clinicians
por: Linkeviciute, Alma, et al.
Publicado: (2022)

Patient-centred management in idiopathic pulmonary fibrosis: similar themes in three communication models
por: Wuyts, Wim A., et al.
Publicado: (2014)

Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial
por: Johansson, Harriet, et al.
Publicado: (2016)

Cancer and fertility preservation: international recommendations from an expert meeting
por: Lambertini, Matteo, et al.
Publicado: (2016)

Chronic lymphocytic leukaemia during pregnancy: management and thoughts
por: Winckler, Patricia, et al.
Publicado: (2015)

Discussing motherhood when the oncological prognosis is dire: ethical considerations for physicians
por: Linkeviciute, Alma, et al.
Publicado: (2020)

On the use of historical estimates
por: Davidov, Ori, et al.
Publicado: (2023)

Can we trust tumour markers in pregnancy after breast cancer? A case of elevated CA 15-3 in the third trimester of pregnancy normalising after delivery
por: Buonomo, Barbara, et al.
Publicado: (2019)

Prognostic interaction between expression of p53 and estrogen receptor in patients with node-negative breast cancer: results from IBCSG Trials VIII and IX
por: Coates, Alan S, et al.
Publicado: (2012)

Biology, staging, and treatment of breast cancer during pregnancy: reassessing the evidences
por: Peccatori, Fedro Alessandro, et al.
Publicado: (2018)

Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
por: Ribi, Karin, et al.
Publicado: (2019)

Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial
por: Ribi, Karin, et al.
Publicado: (2020)

Real de-escalation or escalation in disguise?
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2023)

Interpreting breast international group (BIG) 1-98: a randomized, double-blind, phase III trial comparing letrozole and tamoxifen as adjuvant endocrine therapy for postmenopausal women with hormone receptor-positive, early breast cancer
por: Regan, Meredith M, et al.
Publicado: (2011)

Uterine irradiation as a determinant of infertility and pregnancy losses in young cancer survivors
por: Buonomo, Barbara, et al.
Publicado: (2020)

Breast Cancer during Pregnancy as a Special Type of Early-Onset Breast Cancer: Analysis of the Tumor Immune Microenvironment and Risk Profiles
por: Sajjadi, Elham, et al.
Publicado: (2022)

Frequency of Pregnancy-Associated Cancer: A Systematic Review of Population-Based Studies
por: Dalmartello, Michela, et al.
Publicado: (2020)

Anti-Müllerian hormone as a marker of ovarian reserve and premature ovarian insufficiency in children and women with cancer: a systematic review
por: Anderson, Richard A, et al.
Publicado: (2022)

Precision in Diagnosing and Classifying COPD: Comparison of Historical Height with Current Height and Arm Span to Predict FEV(1)
por: Ansari, Khalid, et al.
Publicado: (2012)

De-escalation in breast cancer surgery
por: Shubeck, Sarah P., et al.
Publicado: (2022)

Music and the historical imagination /
por: Treitler, Leo, 1931-
Publicado: (1989)

Current strategies for the targeted treatment of high-grade serous epithelial ovarian cancer and relevance of BRCA mutational status
por: Gadducci, Angiolo, et al.
Publicado: (2019)

Eight-Year Experience of the Certificate of Competence and Advanced Studies Program Organized by the European School of Oncology
por: Pavlidis, Nicholas, et al.
Publicado: (2021)

Correction to: Eight-Year Experience of the Certifcate of Competence and Advanced Studies Program Organized by the European School of Oncology
por: Pavlidis, Nicholas, et al.
Publicado: (2021)

Changing the landscape of European School of Oncology–European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic
por: Pavlidis, Nicholas, et al.
Publicado: (2022)

Radiobiological Determination of Dose Escalation and Normal Tissue Toxicity in Definitive Chemoradiation Therapy for Esophageal Cancer()
por: Warren, Samantha, et al.
Publicado: (2014)

Estimated Historical and Current Nitrogen Balances for Illinois
por: David, Mark B., et al.
Publicado: (2001)

Cannot write session to /tmp/vufind_sessions/sess_v4l9m51as28lfubrmdqf4eru5u